(Reuters) - Biotechnology stocks will be in the spotlight with a trans-Atlantic takeover deal in the works and Amgen Inc. set to report quarterly earnings after the closing bell.
Anglo-Swedish drug maker AstraZeneca has agreed to buy U.S. biotechnology company MedImmune Inc. for more than $15 billion.
Read more at Reuters.com Hot Stocks News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment